Income before deduction of interest, taxes and amortization: Emergent BioSolutions Inc (EBS)

Brandmark of Emergent BioSolutions Inc. (EBS)

Emergent BioSolutions (EBS) profitability is based on the efficient allocation of government contracts and the duplication of capacities. The gross operating profit before depreciation trend on the GURU.Markets chart shows that the current value is 122.00. However, debt load and dependence on government procurement create financial risks, although the humanitarian status of the products ensures stability amidst global geopolitical tension.

EBS Emergent BioSolutions: Profit before payment of interest, taxes and amortization in the range 11/23/2025 - 11/10/2026

Summary analytical data breakdowns for Emergent BioSolutions Inc. (EBS)

- stock value and consensus price forecast:
Market Chart Emergent Bio|EBS - Price Target Chart
- company stock exchange capitalization indicators:
Market Value Emergent BioSolutions|EBS - Real Price to Acquire Entire Company
- book capitalization information:
Book Value per Share Emergent BioSolutions|EBS - Company Book Value|Market Capitalization to Book Value emergentbiosolutions.com|EBS - Company Total Assets
- company total debt and liquidity indicators:
Debt to Capital Emergent BioSolutions|EBS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Emergent BioSolutions Inc|EBS - Company Aggregate Debts|Debts to Book Value Emergent BioSolutions|EBS - Company Long-Term Debt|Company Short-Term Loans and Borrowings Emergent BioSolutions|Critical Liquidity emergentbiosolutions.com
- business earnings and investment ratios data:
EBS - Net Profit|Expected Net Profit Emergent BioSolutions|EBS - Price to Earnings Ratio|Price to Future Earnings Ratio emergentbiosolutions.com|EBS - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Emergent BioSolutions|EBS - Operating profit before deduction of amortization|Earnings per share for the trailing year Emergent BioSolutions|EBS - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months emergentbiosolutions.com|EBS - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Emergent BioSolutions
Summary company analytics:Emergent BioSolutions
Manufactured product of Emergent Corp

For Emergent BioSolutions (EBS), operating profit reflects the efficiency of its crisis transformation and the divestment of non-core assets, measuring cash flow from core operations before depreciation and interest. Analyzing the EBITDA history allows for an assessment of the revamped management's actual ability to stabilize liquidity, turning this indicator into the primary criterion for evaluating the fair value of capital and the risks of overpayment.

Competitors of Emergent BioSolutions (EBS)

Operating income before deduction of amortization Gilead Corp (GILD)|CDTX - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization NVAX (novavax.com)|CVAC (CureVac) - Operating profit before deduction of amortization|Valneva Corp (VALN) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Vir Bio|TPOXX (SIGA) - Operating income before deduction of amortization|Operating profit EBITDA AVIR|IVVD - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Enanta Pharmaceuticals, Inc. ENTA|INO - Operating profit before deduction of amortization|HilleVax Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Kalaris Tx|dyadic.com (DYAI) - Profit before payment of interest, taxes and amortization|NanoViricides - Income before deduction of interest, taxes and amortization|TLPH (Talphera) - Operating profit EBITDA|COCP - Operating profit before depreciation charges|Operating profit EBITDA TRAW|DWTX - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Qualigen Therapeutics QLGN|ALVR: Operating profit before amortization|VBIV: Operating profit before deduction of amortization|Virios Therapeutics - Company profit before taxes, interest and amortization|VXRT (vaxart.com) - Operating profit before deduction of amortization